Climb Bio CLYM 深 滬
等待開盤 05-12 09:30:00 美东时间
11.53
+0.160
+1.41%
華盛通- 最 高12.48
- 今 開11.43
- 成交量 83.93万股
- 最 低 11.32
- 昨 收 11.37
- 總市值 5.51亿
- 52周最高 12.48
- 市盈率 靜 --
- 換手率 1.76%
- 52周最低 1.16
- 委 比 84.34%
- 總股本 4776.85万
- 歷史最高 29.69
- 量 比 1.05
- 振 幅 10.20%
- 歷史最低 1.05
- 每 手 1
- 風險率 2.61%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 爱彼迎、Affirm、CoreWeave、Datadog、微芯科技等获多家大行上调目标价；HubSpot惨遭14家大行下调目标价
今日重点评级关注：HC Wainwright & Co.：维持Artiva Biotherapeutics"买入"评级，目标价从15美元升至35美元；韦德布什：维持Cullinan Therapeutics"跑赢大市"评级，目标价从36美元升至37美元
05-11 15:43
Climb Bio Q1 EPS $(0.20) Beats $(0.29) Estimate
Climb Bio (NASDAQ:CLYM) reported quarterly losses of $(0.20) per share which beat the analyst consensus estimate of $(0.29) by 31.03 percent. This is a 35.48 percent increase over losses of $(0.31) per share from the
05-07 21:27
美股大行评级 | 潜在涨幅20%！15家机构集体上调AMD目标价；Lumentum、神经分泌生物科学、伊顿公司、美国电力等获多家大行上调目标价
今日重点评级关注：Citizens：维持Avalo Therapeutics"跑赢大市"评级，目标价从52美元升至62美元；BTIG：维持Avalo Therapeutics"买入"评级，目标价从40美元升至58美元
05-07 12:37
U.S. RESEARCH ROUNDUP-IBM, Lumentum Holdings, TransDigm Group
U.S. RESEARCH ROUNDUP-IBM, Lumentum Holdings, TransDigm Group May 6 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including IBM, Lumentum Holdings and TransDigm Group, on Wednesday. HIGHLIGHTS * Advanced Micro Devices AMD.O : Ev
05-06 15:13
美股大行评级 | Stifel上调Lumentum控股目标价从800美元升至1100美元；Pinterest、先进能源工业、安森美半导体、莱迪思半导体、V2X等获多家大行上调目标价
今日重点评级关注：Piper Sandler：维持Aclaris Therapeutics"超配"评级，目标价从7美元升至11美元；Evercore ISI集团：维持BioMarin Pharmaceutical"跑赢大市"评级，目标价从110美元升至120美元
05-06 11:29
Chardan Capital Initiates Coverage On Climb Bio with Buy Rating, Announces Price Target of $22
Chardan Capital analyst Geulah Livshits initiates coverage on Climb Bio (NASDAQ:CLYM) with a Buy rating and announces Price Target of $22.
05-06 02:56
Climb Bio Highlights Budoprutug Progress at R&D Spotlight
The latest announcement is out from Climb Bio ( ($CLYM) ). On May 5, 2026, Clim...
05-05 20:26
U.S. RESEARCH ROUNDUP- Applied Materials, Axsome Therapeutics, Onsemi
U.S. RESEARCH ROUNDUP- Applied Materials, Axsome Therapeutics, Onsemi May 5 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Applied Materials, Axsome Therapeutics and Onsemi on Tuesday. HIGHLIGHTS * Applied Materials AMA
05-05 15:07
Climb Bio raises $110M in private placement; shares up
Climb Bio (CLYM) agreed to raise ~$110M via a private placement with institutional investors. The offering includes 9.48M shares priced at $9.50 per share. Investors will also receive pre-funded warra...
04-28 21:03
美股大行评级 | 瑞银大幅上调西部数据、希捷科技目标价！汇丰银行上调英特尔评级至"买入"，目标价从50美元升至95美元
今日重点评级关注：HC Wainwright & Co.：维持Century Therapeutics"买入"评级，目标价从2美元升至5美元；Oppenheimer：维持Climb Bio"跑赢大市"评级，目标价从10美元升至18美元
04-22 12:41
